Stay updated on Batoclimab in Myasthenia Gravis: Clinical Trial

Sign up to get notified when there's something new on the Batoclimab in Myasthenia Gravis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Batoclimab in Myasthenia Gravis: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page displays the ClinicalTrials.gov record for the phase 3 batoclimab study in adults with generalized myasthenia gravis, including its study design, eligibility criteria, locations, and outcome measures, instead of a 403 error.
    Difference
    86%
    Check dated 2026-11-09T14:45:14.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:26:18.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about a transition, including a terminology change from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T16:32:03.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.1 to v3.7.2; the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T21:44:37.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T04:14:33.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content and displaying the site header/footer, effectively blocking access to the study record.
    Difference
    17%
    Check dated 2026-09-21T22:12:56.000Z thumbnail image

Stay in the know with updates to Batoclimab in Myasthenia Gravis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Batoclimab in Myasthenia Gravis: Clinical Trial page.